Details

---

Manufacturer:

Komedic Sdn. Bhd.

Registration Number (MAL):

MAL19056035AZ

Content

Selegiline hydrochloride
 

Indications

Selegos 5mg is indicated for:

• Parkinson’s Disease: As monotherapy in early stages or as an adjunct to levodopa therapy in advanced stages.

• Symptomatic Parkinsonism: To alleviate symptoms associated with Parkinson’s disease.

 

Instructions

• Dosage: The usual dose is 10 mg daily, either as a single dose in the morning or in two divided doses of 5 mg taken at breakfast and lunch.

• Administration: Swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet.

• Storage: Store below 25°C, in the original package, to protect from light and moisture